Jasmine Crane

Researcher

University of Arkansas for Medical Sciences

unknown

2 h-index 9 pubs 46 cited

Research Areas

Links

Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Jasmine Crane's research focuses on developing and evaluating therapeutic interventions for human papillomavirus (HPV) related conditions, particularly cervical intraepithelial neoplasia (CIN) and head and neck cancer recurrence. She has investigated the efficacy of a peptide-based therapeutic HPV vaccine, PepCan, and its adjuvant, Candida, in Phase I/II and Phase II clinical trials. Her work also explores the impact of cellular pathways, such as Rho/SRF inhibition, on mitochondrial function and sirtuin gene isoforms in both mouse and human models. Crane has collaborated with researchers at the University of Arkansas for Medical Sciences, including David W. Ussery, Nadia Darwish, and Teresa Evans, on multiple publications. Her scholarship metrics include an h-index of 2 with 9 total publications and 46 total citations.

Metrics

h-index: 2
Publications: 9
Citations: 46

Selected Publications

A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026) DOI
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or Candida (2025) DOI
Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3. (2024) DOI
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
Rho/SRF Inhibitor Modulates Mitochondrial Functions (2022) DOI
Sirtuin gene isoforms and genomic sequences of mouse and humans: Divergence across species (2022) DOI